NCT04688164 A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT04675593 Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders Status ACTIVE_NOT_RECRUITING Phase NA
NCT04673383 SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients Status COMPLETED Phase PHASE1/PHASE2
NCT04641780 "Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program" Status UNKNOWN Phase N/A
NCT04638231 Supportive Text Messaging Versus Supportive E-mail Messaging for Patients with Major Depressive Disorder Status COMPLETED Phase NA
NCT04634669 Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE) Status TERMINATED Phase PHASE2
NCT04633096 The Efficacy of Automated Feedback After Internet-based Depression Screening Status COMPLETED Phase NA
NCT04632498 Investigating Biological Markers, Targets, and Intervention for Mood Disorders Status TERMINATED Phase NA
NCT04630964 The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density Status COMPLETED Phase PHASE2
NCT04629599 IPT for Major Depression Following Perinatal Loss: Healing After Loss (HeAL) Status COMPLETED Phase NA
NCT04623814 the Safety, Tolerability, and Pharmacokinetics Study of HEC113995 Status COMPLETED Phase PHASE1
NCT04623034 Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine Status COMPLETED Phase PHASE1
NCT04621708 Pilot Study of the Safety and Tolerability of L-DLPFC iTBS rTMS for MDD in MS Status UNKNOWN Phase NA
NCT04620759 Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE2